New report published by Global Info Research which offers insights on the global Epinephrine market.
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
Click to view the full report TOC, figure and tables:
Global Epinephrine Market: Forecast by Type / Application / Region
As a medication it is used to treat a number of conditions, including anaphylaxis, cardiac arrest, and superficial bleeding.
The major players in global Epinephrine market include: Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma, Harvest Pharmaceuticals, Merit Pharmaceutical and Tianjin Jinyao Group.
On the basis of product, the Epinephrine market is primarily split into: Epinephrine Auto-injector, Epinephrine Prefilled Syringe and Combination Epinephrine Products.
On the basis on the end users/applications covers: Anaphylaxis, Cardiac Arrest and Others.
The global revenue of Epinephrine market was valued at 2246.25 M USD in 2017 and is expected to reach USD 3897.80 M USD in 2025. In the future five years, we predict the CAGR of global revenue is 7.13%.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
In the industry, Mylan Inc profits most in 2016 and recent years, while Impax and ALK Abello ranked 2 and 3.The market share of them is 52.75%, 4.37% and 2.64% in 2017.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are three mainly types of Epinephrine, including Epinephrine Auto-injector, Epinephrine Prefilled Syringe and Combination Epinephrine Products. And Epinephrine Auto-injector is the main type for Epinephrine, and the Epinephrine Auto-injector reached a sales value of approximately 1430.61 M USD in 2017, with 63.69% of global sales value.
Epinephrine technology is much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States Epinephrine Market 2018 Forecast to 2023
Europe Epinephrine Market 2018 Forecast to 2023
North America Epinephrine Market 2018 Forecast to 2023
Asia-Pacific Epinephrine Market 2018 Forecast to 2023
China Epinephrine Market 2018 Forecast to 2023
EMEA Epinephrine Market 2018 Forecast to 2023
Global Epinephrine Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong